Chemistry:Exatecan

From HandWiki
Revision as of 20:11, 5 February 2024 by Unex (talk | contribs) (add)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Exatecan
Exatecan.svg
Names
Preferred IUPAC name
(1S,9S)-1-Amino-9-ethyl-5-fluoro-9-hydroxy-4-methyl-1,2,3,9,12,15-hexahydro-10H,13H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-10,13-dione
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
Properties
C24H22FN3O4
Molar mass 435.455 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references
Tracking categories (test):

Exatecan is a drug which is a structural analog of camptothecin with antineoplastic activity.[1]

A derivative is used in Trastuzumab deruxtecan.

Synthesis

Exatecan synthesis[2]

References

  1. Abou-Alfa, GK; Letourneau, R; Harker, G; Modiano, M; Hurwitz, H; Tchekmedyian, NS; Feit, K; Ackerman, J et al. (20 September 2006). "Randomized Phase III Study of Exatecan and Gemcitabine Compared with Gemcitabine Alone in Untreated Advanced Pancreatic Cancer". Journal of Clinical Oncology 24 (27): 4441–7. doi:10.1200/JCO.2006.07.0201. PMID 16983112. 
  2. H. Terasawa, A. Ejima, S. Ohsuki, K. Uoto, U.S. Patent 5,834,476 (1998).